First human test of new cancer drug halted early
Disease control
Terminated
This early-stage study aimed to test the safety and find the right dose of an experimental drug called BGB-3245 in people with advanced solid tumors that had stopped responding to other treatments. It specifically enrolled patients whose tumors had certain genetic changes in the …
Phase: PHASE1 • Sponsor: MapKure, LLC • Aim: Disease control
Last updated Feb 27, 2026 15:19 UTC